T. P. Vassilakopoulos

785 total citations
19 papers, 502 citations indexed

About

T. P. Vassilakopoulos is a scholar working on Pathology and Forensic Medicine, Genetics and Molecular Biology. According to data from OpenAlex, T. P. Vassilakopoulos has authored 19 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 9 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in T. P. Vassilakopoulos's work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Angiogenesis and VEGF in Cancer (3 papers). T. P. Vassilakopoulos is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Angiogenesis and VEGF in Cancer (3 papers). T. P. Vassilakopoulos collaborates with scholars based in Greece, United States and Germany. T. P. Vassilakopoulos's co-authors include Gerassimos A. Pangalis, Marina P. Siakantaris, M. Angelopoulou, Christos Kittas, Vassiliki A. Boussiotis, P Fessas, Maria K. Angelopoulou, Penelope Korkolopoulou, George Vaiopoulos and Maria Dimopoulou and has published in prestigious journals such as Blood, British Journal of Pharmacology and Bone.

In The Last Decade

T. P. Vassilakopoulos

17 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. P. Vassilakopoulos Greece	12	271	166	160	108	81	19	502
Dimitra Anagnostou Greece	16	303 1.1×	251 1.5×	169 1.1×	110 1.0×	132 1.6×	41	700
László Váróczy Hungary	13	223 0.8×	127 0.8×	85 0.5×	56 0.5×	89 1.1×	47	425
Anjum Hassan United States	16	220 0.8×	93 0.6×	168 1.1×	100 0.9×	88 1.1×	39	540
Gérard Buchonnet France	15	336 1.2×	228 1.4×	229 1.4×	70 0.6×	128 1.6×	27	566
Kazuyoshi Kajimoto Japan	13	162 0.6×	67 0.4×	152 0.9×	124 1.1×	80 1.0×	45	488
Sung Sik Shin United States	15	338 1.2×	128 0.8×	208 1.3×	54 0.5×	100 1.2×	22	647
D Guyotat France	16	142 0.5×	153 0.9×	121 0.8×	94 0.9×	91 1.1×	52	659
Nazan Özsan Türkiye	13	385 1.4×	104 0.6×	213 1.3×	84 0.8×	133 1.6×	46	646
Naoki Kurita Japan	12	121 0.4×	74 0.4×	91 0.6×	93 0.9×	139 1.7×	60	471
Jean Michel Picquenot France	8	318 1.2×	68 0.4×	264 1.6×	74 0.7×	111 1.4×	11	598

Countries citing papers authored by T. P. Vassilakopoulos

Since Specialization

Citations

This map shows the geographic impact of T. P. Vassilakopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. P. Vassilakopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. P. Vassilakopoulos more than expected).

Fields of papers citing papers by T. P. Vassilakopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. P. Vassilakopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. P. Vassilakopoulos. The network helps show where T. P. Vassilakopoulos may publish in the future.

Co-authorship network of co-authors of T. P. Vassilakopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of T. P. Vassilakopoulos. A scholar is included among the top collaborators of T. P. Vassilakopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. P. Vassilakopoulos. T. P. Vassilakopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Sancho, Juan‐Manuel, Zhimin Li, T. P. Vassilakopoulos, et al.. (2025). 7 | POLATUZUMAB VEDOTIN, RITUXIMAB, GEMCITABINE AND OXALIPLATIN (POLA‐R‐GEMOX) FOR RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): PHASE III POLARGO TRIAL. Hematological Oncology. 43(S3).

Zinzani, Pier Luigi, Michelle A. Fanale, Philippe Armand, et al.. (2017). PEMBROLIZUMAB MONOTHERAPY IN PATIENTS WITH PRIMARY REFRACTORY CLASSICAL HODGKIN LYMPHOMA: SUBGROUP ANALYSIS OF THE PHASE 2 KEYNOTE‐087 STUDY. Hematological Oncology. 35(S2). 136–137. 9 indexed citations

Lamprianidou, Eleftheria, T. P. Vassilakopoulos, Sotirios G. Papageorgiou, et al.. (2014). Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine. Blood Cancer Journal. 4(2). e187–e187. 13 indexed citations

Vassilakopoulos, T. P., Gianpaolo Nadali, Maria K. Angelopoulou, et al.. (2012). beta(2)-microglobulin in Hodgkin's lymphoma: prognostic significance in patients treated with ABVD or equivalent regimens.. PubMed. 10(1). 59–69. 5 indexed citations

Anargyrou, Konstantinos, T. P. Vassilakopoulos, Konstantinos Tsionos, et al.. (2011). Low bone mineral density and high bone turnover in patients with non-Hodgkin's lymphoma (NHL) who receive frontline therapy: Results of a multicenter prospective study. Bone. 48. S254–S255. 1 indexed citations

Bouchliou, Irene, Sotirios G. Papageorgiou, Athanasios Galanopoulos, et al.. (2011). 311 STAT signaling alterations in leukemic progenitors can predict the response of myelodysplastic syndrome (MDS) patients to azacytidine. Leukemia Research. 35. S123–S124.

Anargyrou, Konstantinos, Evangelos Terpos, T. P. Vassilakopoulos, et al.. (2008). Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib. Haematologica. 93(3). 451–454. 24 indexed citations

Tecchio, Cristina, Gianpaolo Nadali, Patrizia Scapini, et al.. (2007). High serum levels of B‐lymphocyte stimulator are associated with clinical–pathological features and outcome in classical Hodgkin lymphoma. British Journal of Haematology. 137(6). 553–559. 15 indexed citations

Kalpadakis, Christina, T. P. Vassilakopoulos, Penelope Korkolopoulou, et al.. (2007). Rituximab monotherapy is highly effective in splenic marginal zone lymphoma. Hematological Oncology. 25(3). 127–131. 75 indexed citations

10.

Pyriochou, Anastasia, Stelios Tsigkos, T. P. Vassilakopoulos, et al.. (2007). Anti‐angiogenic properties of a sulindac analogue. British Journal of Pharmacology. 152(8). 1207–1214. 20 indexed citations

11.

Viniou, Nora, T. P. Vassilakopoulos, Maria Dimopoulou, et al.. (2006). FLT3 overexpression in acute promyelocytic leukemia patients without detectable FLT3-ITD or codon 835-836 mutations: a pilot study.. PubMed. 26(2A). 1201–7. 6 indexed citations

12.

Korkolopoulou, Penelope, Irene Thymara, Nikolaos Kavantzas, et al.. (2005). Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications. Leukemia. 19(6). 894–900. 46 indexed citations

13.

Vassilakopoulos, T. P.. (2004). Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma. Blood. 105(5). 1875–1880. 37 indexed citations

14.

Korkolopoulou, Penelope, Maria K. Angelopoulou, Fotios Mitropoulos, et al.. (2001). Evaluation of DNA topoisomerase IIα expression provides independent prognostic information in non‐Hodgkin's lymphomas. Histopathology. 38(1). 45–53. 13 indexed citations

15.

Vassilakopoulos, T. P., Maria K. Angelopoulou, Marina P. Siakantaris, et al.. (2001). Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites. European Journal Of Haematology. 67(5-6). 279–288. 29 indexed citations

16.

Zakynthinos, Epaminondas, et al.. (2001). Echocardiographic and ambulatory electrocardiographic findings in elite water‐polo athletes. Scandinavian Journal of Medicine and Science in Sports. 11(3). 149–155. 10 indexed citations

17.

Pangalis, Gerassimos A., Maria Dimopoulou, Maria K. Angelopoulou, et al.. (2001). Campath-1H (Anti-CD52) Monoclonal Antibody Therapy in Lymphoproliferative Disorders. Medical Oncology. 18(2). 99–108. 54 indexed citations

18.

Pangalis, Gerassimos A., M. Angelopoulou, T. P. Vassilakopoulos, Marina P. Siakantaris, & Christos Kittas. (1999). B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.. PubMed. 36(2). 104–14. 79 indexed citations

19.

Pangalis, Gerassimos A., T. P. Vassilakopoulos, Vassiliki A. Boussiotis, & P Fessas. (1993). Clinical approach to lymphadenopathy.. PubMed. 20(6). 570–82. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact